Frankfurt - Delayed Quote EUR

Medical Properties Trust, Inc. (M3P.F)

Compare
4.4000 -0.0730 (-1.63%)
As of 8:09 AM GMT+2. Market Open.
Loading Chart for M3P.F
DELL
  • Previous Close 4.4730
  • Open 4.4000
  • Bid 4.4000 x 22700
  • Ask 4.5995 x 22100
  • Day's Range 4.4000 - 4.4000
  • 52 Week Range 2.7400 - 9.6700
  • Volume 11,200
  • Avg. Volume 1,549
  • Market Cap (intraday) 2.666B
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -2.2700
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield 0.56 (12.46%)
  • Ex-Dividend Date Jun 10, 2024
  • 1y Target Est 23.42

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

www.medicalpropertiestrust.com

121

Full Time Employees

December 31

Fiscal Year Ends

Recent News: M3P.F

Performance Overview: M3P.F

Trailing total returns as of 6/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

M3P.F
4.43%
S&P 500
13.87%

1-Year Return

M3P.F
40.49%
S&P 500
23.18%

3-Year Return

M3P.F
65.59%
S&P 500
28.60%

5-Year Return

M3P.F
58.28%
S&P 500
88.14%

Compare To: M3P.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: M3P.F

Valuation Measures

Annual
As of 6/14/2024
  • Market Cap

    2.71B

  • Enterprise Value

    12.06B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.63

  • Price/Book (mrq)

    0.43

  • Enterprise Value/Revenue

    16.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -181.91%

  • Return on Assets (ttm)

    0.11%

  • Return on Equity (ttm)

    -19.34%

  • Revenue (ttm)

    805.27M

  • Net Income Avi to Common (ttm)

    -1.47B

  • Diluted EPS (ttm)

    -2.2700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    224.34M

  • Total Debt/Equity (mrq)

    150.63%

  • Levered Free Cash Flow (ttm)

    882.13M

Research Analysis: M3P.F

Company Insights: M3P.F

Research Reports: M3P.F

People Also Watch